Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-08

Clinical Trial Update: Liposomal Bupivacaine vs Adductor Canal Block in Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 trial comparing liposomal bupivacaine to adductor canal block in knee surgery is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adductor canal block
  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Texas Orthopaedics, Sports and Rehabilitation Associates | Conditions: Knee Osteoarthritis | Phase 4 | Status: COMPLETED